Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: Chi Wong who wrote (2982)	4/4/2000 2:04:00 AM
From: Gary Mohilner	Read Replies (1) \| Respond to of 5665

Chi, I think you're right, however, don't discount milestones for telling a story. I believe that their are some of the largest payment coming soon, one for SBH starting the Multi-Dose Trial, one for IMGN completing the single dose trial. At that point IMGN will have completed its involvement, and I believe half or something over that will have been paid to IMGN. Milestones should also give us some feel for how Phase 2 is proceeding, if they don't immediately go into an Expedited Phase 3. If we do, substantial Milestone Payments should let us know. I also think if patients start going into complete remission, word will get out. When it does, I believe SBH/IMGN will be more public about it. Gary